
Michael P. Teske MD
Retinal Disease
Professor Emeritus , Ophthalmology & Visual Sciences, University of Utah School of Medicine
Join to view full profile
65 N Medical DrSalt Lake City, UT 84132
Phone+1 801-581-2352
Dr. Teske is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Teske is an ophthalmologist based in Salt Lake City, UT, specializing in retinal diseases. He completed his residency in ophthalmology at the University of Utah Health and graduated in 1982 from the David Geffen School of Medicine at UCLA. He is experienced in vitreoretinal and pediatric retinal diseases. Dr. Teske has contributed to several publications focused on drug delivery systems and retinal diseases, with notable citations in the field. His recognition includes being named a Regional Top Doctor by Castle Connolly and receiving the CMS Meaningful Use Stage 1 Certification. He is also a Fellow of the American Academy of Ophthalmology.
Education & Training
University of Utah HealthResidency, Ophthalmology, 1982 - 1986
David Geffen School of Medicine at UCLAClass of 1982
Certifications & Licensure
UT State Medical License 1983 - 2028
MI State Medical License 1986 - 1990
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2016
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- Is occlusive retinal vascular disease linked to hereditary spherocytosis postsplenectomy? A case series.Frida Velcani, Shivesh Shah, Brian E Zaugg, Michael P Teske, Nikhil N Batra
Journal of Medical Case Reports. 2025-12-30 - 19 citationsInfluence of Drug Incorporation on the Physico-Chemical Properties of Poly(l-Lactide) Implant Coating Matrices-A Systematic Study.Daniela Arbeiter, Thomas Reske, Michael Teske, Dalibor Bajer, Volkmar Senz
Polymers. 2021-01-18 - 12 citationsSmart releasing electrospun nanofibers-poly: L.lactide fibers as dual drug delivery system for biomedical application.Katharina Wulf, Daniela Arbeiter, Claudia Matschegewski, Michael Teske, Jennifer Huling
Biomedical Materials. 2020-12-16
Journal Articles
- Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients with Autosomal Dominant Retinitis PigmentosaDavid G Birch, Michael P Teske, Richard G Weleber, Byron L Lam, Judith Warner, Gary Edd Fish, Neal L Sklaver, Mark E Pennesi, John Heckenlively, Paul S Bernstein, Karl..., JAMA
Press Mentions
Retina Specialist Joseph Simonett, MD, Joins Moran Eye CenterSeptember 15th, 2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









